转移膜市场 - 全球产业规模、份额、趋势、机会及预测（按产品、转移方法、应用、最终用户、地区和竞争格局划分），2021-2031年

全球传热膜市场预计将从 2025 年的 4.7215 亿美元成长到 2031 年的 6.7393 亿美元，复合年增长率为 6.11%。

这些转移膜是特製的微孔薄膜，通常由聚二氟亚乙烯(PVDF)、硝化纤维素或尼龙等材料製成。它们用于固定核酸和蛋白质，例如在西方印渍术)等技术中，以便进行后续检测。市场成长的主要驱动力是慢性病发病率的上升和生物製药领域资金的增加，这推动了对各种蛋白质分析和诊断测试的需求。根据欧洲製药工业协会联合会 (EFPIA) 的报告，预计到 2024 年，欧洲製药业将在研发方面投资约 550 亿欧元，这凸显了大量资金的流入，从而满足了对这些关键实验室耗材的高需求。

然而，由于替代检测技术的兴起，市场面临着巨大的挑战。数位分析平台和自动化印迹系统的日益普及，为大幅减少传统物理膜的使用提供了可能。这种向自动化和数数位化的转变可能会扰乱标准转印媒体的持续销售量，从而对该细分市场的持续成长构成潜在障碍。

市场驱动因素

全球感染疾病和慢性病负担日益加重，是推动全球转印膜市场发展的主要动力。随着癌症等疾病的日益普遍，对可靠的蛋白质分析技术（例如蛋白质印迹法）和用于检测生物标记的诊断工具的需求也与日俱增。需要进行分析的诊断数量之多，更凸显了这种迫切性。例如，美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告预测，光是当年美国就将新增2,041,910例癌症病例。因此，这些疾病发生率的不断上升，直接要求为用于治疗监测和疾病检测等关键流程的转印膜建立一条稳健的供应链。

同时，生物製药研发投入的不断增加，为药物发现所需的大规模实验室运作提供了资金，从而推动了市场成长。製药公司正投入创纪录的资金用于新型生物製药的研发，而使用微孔膜的蛋白质序列测定工作流程是这个过程的关键。例如，默克公司于2025年2月发布的「2024年第四季及全年财务业绩」显示，该公司全年非GAAP研发支出达到179亿美元。这项企业投资，加上公共部门资金的进一步支持，巩固了实验室耗材生态系统。 2024年，美国卫生与公众服务部报告称，美国国立卫生研究院（NIH）的总预算支出达到473亿美元。这些资金投入确保了学术界和商业研究机构对高品质转染培养基的持续需求。

市场挑战

由于替代检测技术的出现和自动化印迹系统的日益普及，全球转印膜市场面临巨大的成长障碍。先进的数位平台通常采用液相法和毛细管电泳技术，往往可以消除或显着减少对聚二氟亚乙烯和硝化纤维素等传统微孔膜的需求。随着越来越多的实验室将重现性和效率放在首位，手动Western印迹技术的衰落直接导致标准转印膜的重复销售量下降，从而限制了膜生产商的商机。

这种转变体现在产业对自动化实验室解决方案的参与度不断提高，这些解决方案与传统耗材直接竞争。据实验室自动化与筛检协会 (SLAS) 称，2024 年国际会议暨展览将吸引创纪录的 7500 名与会者和 400 家参展。如此大规模的参与证实了产业正加速向自动化技术转型，这些技术能够优化试剂使用并最大限度地减少物理废弃物，从而逐步降低现代蛋白质分析工作流程中对传统转印膜的需求。

市场趋势

自动化和单细胞西方印渍术平台的兴起，正从根本上改变市场格局，其高通量能力和可重复性远胜于传统的手动方法。实验室正日益采用单细胞分辨率工具和数位成像系统，以提高数据准确性并简化复杂的蛋白质分析流程。各大厂商正积极支持这项技术转型，推出满足新一代印迹解决方案需求的整合系统。例如，Bio-Rad Laboratories, Inc. 在 2024 年年度报告（2025 年 3 月发布）中宣布，将于 2024 年推出两款全新的生命科学研究平台：ChemiDoc Go 成像系统和 ddSEQ 单细胞试剂盒。这些平台旨在满足不断变化的研究需求，并提高实验效率。

同时，随着产业适应全球永续性要求，向无溶剂、环保膜製造的转型正在加速。生物技术和製药公司优先考虑低碳供应链，这促使耗材供应商创新研发无溶剂生产工艺，并减少与转移介质相关的塑胶废弃物。这一趋势体现在整个产业设定雄心勃勃的气候目标上，这些目标直接影响着筹资策略。根据My Green Lab于2024年11月发布的《2024年生物技术和製药行业碳影响报告》，该行业31%的公司已设定与1.5°C排放目标相一致的中期范围1和范围2减排目标，从而对支持这些环境目标的永续实验室材料产生了强劲的需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球传输膜市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产物（聚偏氟乙烯、硝化纤维素、尼龙）
  • 按转印法（湿式或槽式转印、半干式电转印、干式电转印、其他）
  • 透过应用（蛋白质印迹法、蛋白质印迹法、蛋白质印迹法等）
  • 依最终用户（生物製药/製药公司、学术/研究机构、诊断检查室、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美传输膜市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲传输膜市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区传输膜市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲传输膜市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲传输膜市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球传质膜市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Abcam Plc.
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Azure Bio systems Inc.
• Advansta Inc.
• GVS SpA

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Transfer Membrane Market is projected to expand from USD 472.15 Million in 2025 to USD 673.93 Million by 2031, registering a CAGR of 6.11%. These transfer membranes are specialized microporous films, usually made from materials like polyvinylidene difluoride (PVDF), nitrocellulose, or nylon, and are engineered to immobilize nucleic acids and proteins for subsequent detection in methods such as Western blotting. Market growth is largely propelled by the increasing incidence of chronic diseases alongside rising biopharmaceutical funding, which drives the need for extensive protein analysis and diagnostic testing. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector invested approximately €55 billion in research and development across Europe in 2024, highlighting the significant capital flow that supports the high demand for these critical laboratory consumables.

Conversely, the market faces a significant obstacle stemming from the rise of alternative detection technologies. The growing uptake of digital analysis platforms and automated blotting systems offers a method to considerably lower the usage of traditional physical membranes. This shift toward automation and digitization threatens to impede the volume of recurring sales for standard transfer media, presenting a potential barrier to sustained market growth in this segment.

Market Driver

The escalating global burden of infectious and chronic diseases acts as a major driver for the Global Transfer Membrane Market. As conditions such as cancer become more prevalent, there is a heightened demand for dependable protein analysis techniques, such as Western blotting, and diagnostic tools to detect biomarkers. This urgency is underscored by the sheer volume of diagnoses requiring analysis; for instance, the American Cancer Society's 'Cancer Facts & Figures 2025' report from January 2025 projects that 2,041,910 new cancer cases will be diagnosed in the United States alone during that year. Consequently, the growing incidence of these diseases creates a direct necessity for resilient supply chains of transfer membranes utilized in the essential processes of therapeutic monitoring and disease detection.

Concurrently, increased investment in biopharmaceutical research and development is fueling market growth by financing the extensive laboratory operations needed for drug discovery. Pharmaceutical companies are directing record amounts of capital toward developing novel biologics, a process that relies heavily on protein sequencing workflows involving these microporous films. To illustrate, Merck's 'Fourth-Quarter and Full-Year 2024 Financial Results' from February 2025 revealed that the company's non-GAAP research and development expenses hit $17.9 billion for the full year. This corporate investment is bolstered by public sector funding, which further secures the ecosystem for laboratory consumables; in 2024, the U.S. Department of Health and Human Services reported that the National Institutes of Health (NIH) received a total enacted program level of $47.3 billion. Collectively, these financial commitments guarantee a continuous demand for high-grade transfer media across both academic and commercial research environments.

Market Challenge

The Global Transfer Membrane Market encounters a substantial barrier to growth arising from the advent of alternative detection technologies and the rising implementation of automated blotting systems. Advanced digital platforms, which frequently employ fluid-based methods or capillary electrophoresis, often eliminate or significantly decrease the need for traditional microporous films like polyvinylidene difluoride and nitrocellulose. As laboratories increasingly value reproducibility and efficiency, the transition away from manual Western blotting techniques leads to a direct reduction in recurring sales volumes for standard transfer media, thereby restricting revenue opportunities for membrane manufacturers.

This shift is highlighted by growing industrial involvement with automated laboratory solutions that compete directly with traditional consumables. According to the Society for Laboratory Automation and Screening, its 2024 International Conference and Exhibition drew a record 7,500 attendees and 400 exhibitors. Such significant participation underscores the accelerating industry trend toward automation technologies that optimize reagent use and minimize physical waste, a movement that is progressively diminishing the demand for conventional transfer membranes within modern protein analysis workflows.

Market Trends

The movement toward automated and single-cell Western blotting platforms is fundamentally transforming the market by emphasizing high-throughput capabilities and reproducibility over conventional manual methods. Laboratories are increasingly adopting single-cell resolution tools and digital imaging systems to improve data accuracy and simplify complex protein analysis workflows. Leading manufacturers are actively supporting this technological shift by releasing integrated systems to satisfy the need for next-generation blotting solutions. For example, Bio-Rad Laboratories noted in its '2024 Annual Report' from March 2025 that it launched two new Life Science research platforms in 2024-the ChemiDoc Go Imaging System and the ddSEQ Single-Cell Kit-specifically engineered to meet these changing research requirements and enhance experimental efficiency.

Simultaneously, the transition toward solvent-free and eco-friendly membrane manufacturing is accelerating as the industry conforms to global sustainability mandates. Biotechnology and pharmaceutical organizations are prioritizing low-carbon supply chains, which compels consumable suppliers to innovate solvent-free production techniques and decrease plastic waste related to transfer media. This push is quantified by the ambitious climate targets being set throughout the sector, which directly impact procurement strategies. According to the '2024 Carbon Impact of Biotech & Pharma Report' by My Green Lab in November 2024, 31% of companies in the industry have established medium-term Scope 1 and 2 targets consistent with a 1.5°C pathway, generating strong demand for sustainable laboratory materials that support these environmental goals.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Abcam Plc.
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Azure Bio systems Inc.
• Advansta Inc.
• GVS S.p.A.

Report Scope

In this report, the Global Transfer Membrane Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transfer Membrane Market, By Product

• PVDF
• Nitrocellulose
• Nylon

Transfer Membrane Market, By Transfer Method

• Wet or Tank Transfer
• Semi-dry Electro Blotting (Semi-dry Transfer)
• Dry Electro Blotting (Dry Transfer)
• Others

Transfer Membrane Market, By Application

• Western Blotting
• Southern Blotting
• Northern Blotting
• Others

Transfer Membrane Market, By End User

• Biopharmaceutical & Pharmaceutical Companies
• Academic & Research Institutes
• Diagnostic Labs
• others

Transfer Membrane Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Transfer Membrane Market.

Available Customizations:

Global Transfer Membrane Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transfer Membrane Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (PVDF, Nitrocellulose, Nylon)
  • 5.2.2. By Transfer Method (Wet or Tank Transfer, Semi-dry Electro Blotting (Semi-dry Transfer), Dry Electro Blotting (Dry Transfer), Others)
  • 5.2.3. By Application (Western Blotting, Southern Blotting, Northern Blotting, Others)
  • 5.2.4. By End User (Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes, Diagnostic Labs, others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Transfer Membrane Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Transfer Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Transfer Membrane Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Transfer Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Transfer Membrane Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Transfer Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Transfer Membrane Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Transfer Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Transfer Membrane Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Transfer Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Transfer Membrane Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Transfer Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Transfer Membrane Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Transfer Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Transfer Membrane Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Transfer Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Transfer Membrane Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Transfer Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Transfer Membrane Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Transfer Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Transfer Membrane Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Transfer Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Transfer Membrane Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Transfer Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Transfer Membrane Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Transfer Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Transfer Membrane Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Transfer Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Transfer Membrane Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Transfer Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Transfer Membrane Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Transfer Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Transfer Membrane Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Transfer Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Transfer Membrane Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Transfer Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Transfer Membrane Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Transfer Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Transfer Membrane Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Transfer Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Transfer Membrane Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Transfer Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Transfer Membrane Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Transfer Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Transfer Membrane Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Transfer Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Transfer Membrane Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Transfer Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Transfer Membrane Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Merck KGaA
• 15.4. PerkinElmer, Inc.
• 15.5. Abcam Plc.
• 15.6. Santa Cruz Biotechnology, Inc.
• 15.7. ATTO Corporation
• 15.8. Azure Bio systems Inc.
• 15.9. Advansta Inc.
• 15.10. GVS S.p.A.

16. Strategic Recommendations

17. About Us & Disclaimer